Z16.34 - Resistance to antimycobacterial drug(s)

  • Applicable to Resistance to antimycobacterial drug(s)
  • The 2025 edition of ICD10-CM Z16.34 became effective on October 1, 2024.
  • This is the American ICD10-CM version of Z16.34 - other international versions of ICD10 Z16.34 may differ.
  • Z16.34 is a Non-Billable / Non-Specific ICD10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • Z16.34 Code should not be used for billing or reimbursement purposes as there are multiple ICD-10 CM codes below it that contain a greater level of detail.
  • Z16.34 - Resistance to antimycobacterial drug(s)
    • Z16.34 - Resistance to antimycobacterial drug(s)
    • Z16.341 - Resistance to single antimycobacterial drug
    • Z16.342 - Resistance to multiple antimycobacterial drugs

 Inclusion Term

  • Resistance to tuberculostatics

The following codes above Z16.34 contain annotation back-references that may be applicable to Z16.34:

Chapter: Z00-Z99 Factors influencing health status and contact with health services

Section: Z16 Resistance to antimicrobial drugs

Category: Z16 Resistance to antimicrobial drugs

resistance icd 10
 
antimycobacterial icd 10
 
antimicrobial icd 10
 
drugs icd 10
 
Non-Billable/Non-Specific Code

Browse other similar CM codes

Z16.1
 
Z16.10
 
Z16.11
 
Z16.12
 
Z16.13
 
Z16.19
 
Z16.2
 
Z16.20
 
Z16.21
 
Z16.22
 
Z16.23
 
Z16.24
 
Z16.29
 
Z16.3
 
Z16.30
 
Z16.31
 
Z16.32
 
Z16.33
 
Z16.34
 
Z16.341
 
Z16.342
 
Z16.35
 
Z16.39
 

Please, give attribution to our website icd-10code.com